封面
市場調查報告書
商品編碼
2114218

PTCA球囊導管市場:市場規模、佔有率、監管、報銷、治療方法及細分市場預測(至2036年)

PTCA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

經皮冠狀動脈腔內成形術(PTCA)是一種無需開胸手術即可恢復阻塞冠狀動脈血流的介入治療方法。此手術通過擴張導管末端的球囊,壓迫阻塞的斑塊,因而疏通血管。由於其微創性,PTCA已成為主要的介入治療方式。

本報告提供39個目標國家的彩色編碼、引證市場模型,包括基於流行病學資料的按適應症分類的治療統計資料。互動式Excel資料包含市場規模(價值和銷售)、產品使用情況、平均售價以及公司佔有率/排名分析(如有)。此外,分析師的定性評論說明了定量數據的背景和市場環境。

市場模式的主要內容

目前可用的PTCA球囊導管及不斷變化的競爭格局:

  • 對主要行業趨勢的詳細分析
  • PTCA球囊導管市場年度總銷售額及市場展望:按細分市場分類
  • 按細分市場分類的詳細數據,包括總治療量、銷售量、平均售價和市場規模。

全球、區域和國家/地區特定市場洞察:

  • 全球趨勢按地區進一步細分,GlobalData 分析師提供特定市場的定性資訊和特定國家的市場分析。
  • PTCA球囊導管市場SWOT分析
  • 深入分析PTCA球囊導管市場的競爭考察與發展趨勢。

一份真正全面的整體情況,包括對醫療保健系統的概要介紹,將加深您對市場的理解。市場進入部分則透過提供有關報銷政策和法規環境的信息,對市場趨勢進行更詳細的分析。

  • 各國醫療保健系統概況
  • 各國具體的還款政策
  • 各國醫療科技監管狀況

目標公司:Shockwave Medical Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Biotronik SE & Co KG, Terumo Corp, Koninklijke Philips NV, Microport Scientific Corp, Lepu Medical Technology (Beijing) Co Ltd, OrbusNeich, Nipro Corp, Cordis Corp, iVascular SLU等

目標國家:美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷、智利

購買的好處

運用這種市場模式,可以達成以下目標:

  • 透過確定關鍵公司並仔細審查其開發平臺中的產品,您可以製定和設計引進和引進許可策略。
  • 了解影響和驅動PTCA球囊導管市場的趨勢,將有助於您制定業務策略。
  • 透過了解關鍵趨勢、創新產品和技術、市場區隔以及未來可能影響PTCA球囊導管市場的公司,您可以增加收入。
  • 透過了解競爭格局並分析領導企業的市場佔有率,您可以製定有效的銷售和行銷策略。
  • 我們尋找具有強大產品系列潛力的新興企業,並制定有效的應對策略以獲得競爭優勢。
  • 您可以追蹤 2015 年至 2036 年全球及各國PTCA球囊導管醫療設備市場的銷售趨勢。
  • 您可以確定在整合、投資和策略聯盟方面提供最大機會的市場類別和細分市場,並據此系統化您的銷售和行銷活動。
簡介目錄
Product Code: GDME676MM

PTCA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Percutaneous Transluminal Coronary Angioplasty (PTCA) is a intervention that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. In this intervention, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque. PTCA has become the basic interventional modality because of its minimally invasive nature.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed PTCA Balloon Catheters and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total PTCA Balloon Catheters market revenue by segment and market outlooks from 2015-2036.
  • Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for PTCA Balloon Catheters market.
  • Competitive dynamics insights and trends provided for PTCA Balloon Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Shockwave Medical Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Biotronik SE & Co KG, Terumo Corp, Koninklijke Philips NV, Microport Scientific Corp, Lepu Medical Technology (Beijing) Co Ltd, OrbusNeich, Nipro Corp, Cordis Corp, iVascular SLU and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the PTCA Balloon Catheters marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving PTCA Balloon Catheters market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the PTCA Balloon Catheters market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific PTCA Balloon Catheters market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.